SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-018016
Filing Date
2021-04-07
Accepted
2021-04-07 16:16:08
Documents
5
Period of Report
2021-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A rlay-def14a_20210519.htm DEF 14A 895131
2 GRAPHIC gdnzhdfvnais000001.jpg GRAPHIC 31128
3 GRAPHIC gdnzhdfvnais000003.jpg GRAPHIC 90803
4 GRAPHIC gdnzhdfvnais000004.jpg GRAPHIC 62192
5 GRAPHIC gdnzhdfvnais000002.jpg GRAPHIC 31128
  Complete submission text file 0001564590-21-018016.txt   1193163
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39385 | Film No.: 21812290
SIC: 2836 Biological Products, (No Diagnostic Substances)